ArticleMolecular neurobiology2026

Establishing a Diagnostic Model Based on Plasma CDR1as and Alpha-Synuclein for Mild Cognitive Impairment in Type 2 Diabetes.

Wencan Ji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.